epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Coreg

carvedilol

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 3.125 mg, 6.25 mg, 12.5 mg, 25 mg

HTN

[6.25-25 mg PO bid]
Start: 6.25 mg PO bid, may double dose q1-2wk; Max: 50 mg/day; Info: give with food; taper dose over 1-2wk to D/C

heart failure with reduced ejection fraction

[25-50 mg PO bid]
Start: 3.125 mg PO bid, may double dose q2wk; Max: 50 mg/day; 100 mg/day if >85 kg; Info: minimize fluid retention prior to tx; give with food; taper dose over 1-2wk to D/C

left ventricular dysfunction, post-MI

[25 mg PO bid]
Start: 6.25 mg PO bid ASAP after patient stable, then double dose q3-10 days; Info: minimize fluid retention prior to tx; start 3.125 mg PO bid and/or titrate slower if fluid retention, hypotension, or bradycardia; give with food; taper dose over 1-2wk to D/C

atrial fibrillation/flutter (off-label)

[3.125-25 mg PO bid]
Alt: 3.125-50 mg PO bid; Info: for maintenance rate control; give with food; taper dose over 1-2wk to D/C

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined

hepatic dosing

[see below]
hepatic impairment: avoid use

Peds Dosing .

Dosage forms:  TAB: 3.125 mg, 6.25 mg, 12.5 mg, 25 mg

heart failure with reduced ejection fraction (off-label)

[1-23 mo]
Dose: 0.2-3 mg/kg/day PO divided bid-tid; Start: 0.05 mg/kg/day divided bid-tid, may incr. dose q2wk; Max: 3 mg/kg/day; Info: minimize fluid retention prior to tx; give with food; taper dose over 1-2wk to D/C
[2-11 yo]
Dose: 0.2-2 mg/kg/day PO divided bid; Start: 0.05 mg/kg/day divided bid, may incr. dose q2wk; Max: 2 mg/kg/day; Info: minimize fluid retention prior to tx; give with food; taper dose over 1-2wk to D/C
[12 yo and older]
Dose: 0.2-1 mg/kg/day PO divided bid; Start: 0.05 mg/kg/day divided bid, may incr. dose q2wk; Max: 50 mg/day; Info: minimize fluid retention prior to tx; give with food; taper dose over 1-2wk to D/C

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined

hepatic dosing

[not defined]
hepatic impairment: consider adult hepatic dosing for guidance

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@5becddf1
  • hypersensitivity to drug or ingredient
  • bradycardia, severe
  • AV block, 2nd-3rd degree
  • heart failure, decompensated
  • cardiogenic shock
  • sick sinus syndrome (patients without pacemaker)
  • bronchial asthma
  • hepatic impairment
  • abrupt withdrawal
  • caution: hypersensitivity to tartrazine (some generic forms)
  • caution: PVD
  • caution: Prinzmetal angina
  • caution: bronchospastic disease
  • caution: surgery, major
  • caution: diabetes mellitus
  • caution: fasting
  • caution: thyroid disorder
  • caution: WPW syndrome
  • caution: pheochromocytoma
  • caution: renal impairment
  • caution: myasthenia gravis
  • caution: anaphylactic reaction history, severe
  • caution: CYP2D6 poor metabolizers
  • caution: elderly patients

Drug Interactions .

Overview

carvedilol

beta blocker

Interaction Characteristics:
  • CYP2C9 substrate
  • CYP2D6 substrate
  • P-gp substrate
  • P-gp inhibitor, moderate
  • antihypertensive agent
  • binds to cation exchange resin/polymer
  • bradycardia
  • delays atrioventricular conduction
  • hyperglycemic effects
  • hypoglycemic effects

Contraindicated

  • colchicine
  • Coreg (carvedilol)
    +
    colchicine
    1 interaction

    Contraindicated

    carvedilol + colchicine

    CV RISK REDUCTION: consider alternative or monitor CK, myopathy s/sx; GOUT or FMF: contraindicated in pts w/ renal or hepatic impairment; otherwise, decr. colchicine dose based on indication during and x14 days after carvedilol use as follows: GOUT PROPHYLAXIS: give colchicine 0.3 mg qod-qd; ACUTE GOUT TX: give colchicine 0.6 mg x1 only; FMF: decr. max colchicine dose to 0.6 mg/day divided qd-bid: combo may incr. colchicine levels, risk of myopathy, rhabdomyolysis, other life-threatening toxicity (P-gp-mediated transport inhibited)

  • isocarboxazid
  • Coreg (carvedilol)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    carvedilol + isocarboxazid

    contraindicated: combo may incr. risk of hypotension, including orthostasis (additive effects)

Avoid/Use Alternative

  • acebutolol
  • Coreg (carvedilol)
    +
    acebutolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + acebutolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects, duplicate therapy)

  • albuterol
  • Coreg (carvedilol)
    +
    albuterol
    1 interaction

    Avoid/Use Alternative

    carvedilol + albuterol

    use alternative or monitor BP, asthma sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • albuterol inhaled
  • Coreg (carvedilol)
    +
    albuterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + albuterol inhaled

    use alternative or monitor BP, asthma sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • aldesleukin
  • Coreg (carvedilol)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    carvedilol + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • apixaban
  • Coreg (carvedilol)
    +
    apixaban
    1 interaction

    Avoid/Use Alternative

    carvedilol + apixaban

    ADULT PTS: monitor bleeding s/sx; if also combined w/ strong CYP3A4 inhibitor, decr. apixaban 5 mg bid or 10 mg bid dose by 50% or avoid combo if already on 2.5 mg bid; PEDS PTS: monitor bleeding s/sx; if also combined w/ strong CYP3A4 inhibitor, consider decr. apixaban dose: combo may incr. apixaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • arformoterol inhaled
  • Coreg (carvedilol)
    +
    arformoterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + arformoterol inhaled

    use alternative or monitor BP, COPD sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • aripiprazole lauroxil
  • Coreg (carvedilol)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    carvedilol + aripiprazole lauroxil

    ARISTADA INITIO: avoid combo; ARISTADA: monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • atenolol
  • Coreg (carvedilol)
    +
    atenolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + atenolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects, duplicate therapy)

  • betaxolol
  • Coreg (carvedilol)
    +
    betaxolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + betaxolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • bisoprolol
  • Coreg (carvedilol)
    +
    bisoprolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + bisoprolol

    avoid combo: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects, duplicate therapy)

  • brigatinib
  • Coreg (carvedilol)
    +
    brigatinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + brigatinib

    use alternative or monitor BP, HR: combo may incr. risk of bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • carvedilol
  • Coreg (carvedilol)
    +
    carvedilol
    1 interaction

    Avoid/Use Alternative

    carvedilol + carvedilol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • ceritinib
  • Coreg (carvedilol)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + ceritinib

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia (additive effects)

  • clonidine
  • Coreg (carvedilol)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    carvedilol + clonidine

    if ADHD use, avoid combo; otherwise, monitor BP, HR; D/C carvedilol prior to clonidine taper: combo may incr. risk of hypotension (including orthostasis), PR interval prolongation, AV block, bradycardia, severe rebound HTN on alpha-2 agonist withdrawal (additive effects; antagonistic effects, unopposed alpha adrenergic stimulation)

  • crizotinib
  • Coreg (carvedilol)
    +
    crizotinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + crizotinib

    use alternative or monitor HR, BP: combo may incr. risk of bradycardia (additive effects)

  • dabigatran
  • Coreg (carvedilol)
    +
    dabigatran
    1 interaction

    Avoid/Use Alternative

    carvedilol + dabigatran

    ATRIAL FIBRILLATION: avoid combo if CrCl <30 mL/min; OTHER INDICATIONS: avoid combo if CrCl <50 mL/min; if dabigatran use for DVT/PE prophylaxis post-hip replacement and CrCl >50 mL/min, consider separating admin. at least 2h apart: combo may incr. dabigatran levels, risk of bleeding (including life-threatening), other adverse effects (P-gp-mediated transport inhibited)

  • doxorubicin
  • Coreg (carvedilol)
    +
    doxorubicin
    1 interaction

    Avoid/Use Alternative

    carvedilol + doxorubicin

    avoid combo: combo may incr. doxorubicin levels, risk of serious infection, myelosuppression, cardiotoxicity, other adverse effects (P-gp-mediated transport inhibited)

  • ensartinib
  • Coreg (carvedilol)
    +
    ensartinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + ensartinib

    avoid combo: combo may incr. ensartinib levels, risk of bradycardia, hyperglycemia, other adverse effects (P-gp-mediated transport possibly inhibited, additive effects)

  • epinephrine
  • Coreg (carvedilol)
    +
    epinephrine
    1 interaction

    Avoid/Use Alternative

    carvedilol + epinephrine

    use alternative or monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • esmolol
  • Coreg (carvedilol)
    +
    esmolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + esmolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • etrasimod
  • Coreg (carvedilol)
    +
    etrasimod
    1 interaction

    Avoid/Use Alternative

    carvedilol + etrasimod

    consider alternative or monitor BP, HR, ECG, especially when adding carvedilol to existing etrasimod tx: combo may incr. risk of PR interval prolongation, AV block, bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • fenoldopam
  • Coreg (carvedilol)
    +
    fenoldopam
    1 interaction

    Avoid/Use Alternative

    carvedilol + fenoldopam

    use alternative or monitor BP: combo may incr. risk of hypotension (beta blocker interference with reflex tachycardia; additive effects)

  • fexinidazole
  • Coreg (carvedilol)
    +
    fexinidazole
    1 interaction

    Avoid/Use Alternative

    carvedilol + fexinidazole

    if possible, do not initiate fexinidazole until 5 half-lives after carvedilol D/C; use alternative or monitor ECG during and x7 days after fexinidazole tx: combo may incr. risk of QT prolongation, cardiac arrhythmias (bradycardia may incr. risk of QT prolongation)

  • fingolimod
  • Coreg (carvedilol)
    +
    fingolimod
    1 interaction

    Avoid/Use Alternative

    carvedilol + fingolimod

    use alternative or monitor BP, HR, ECG overnight, esp. during fingolimod initiation/titration: combo may incr. risk of PR interval prolongation, AV block, bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • formoterol inhaled
  • Coreg (carvedilol)
    +
    formoterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + formoterol inhaled

    use alternative or monitor BP, COPD sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • labetalol
  • Coreg (carvedilol)
    +
    labetalol
    1 interaction

    Avoid/Use Alternative

    carvedilol + labetalol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects, duplicate therapy)

  • landiolol
  • Coreg (carvedilol)
    +
    landiolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + landiolol

    avoid combo: combo may incr. risk of PR interval prolongation, AV block, bradycardia, hypotension, other adverse effects (additive effects, duplicate therapy)

  • lenacapavir
  • Coreg (carvedilol)
    +
    lenacapavir
    1 interaction

    Avoid/Use Alternative

    carvedilol + lenacapavir

    avoid combo if also combined w/ strong CYP3A4 and UGT1A1 inhibitors; otherwise, caution advised: combo may incr. lenacapavir levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • levalbuterol inhaled
  • Coreg (carvedilol)
    +
    levalbuterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + levalbuterol inhaled

    use alternative or monitor BP, bronchospasm sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • lofexidine
  • Coreg (carvedilol)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    carvedilol + lofexidine

    use alternative or monitor BP, HR: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • metoprolol
  • Coreg (carvedilol)
    +
    metoprolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + metoprolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • nadolol
  • Coreg (carvedilol)
    +
    nadolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + nadolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects, duplicate therapy)

  • nebivolol
  • Coreg (carvedilol)
    +
    nebivolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + nebivolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects, duplicate therapy)

  • neratinib
  • Coreg (carvedilol)
    +
    neratinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + neratinib

    avoid combo if also combined w/ strong-mod CYP3A4 inhibitor; otherwise, caution advised: combo may incr. neratinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • olodaterol inhaled
  • Coreg (carvedilol)
    +
    olodaterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + olodaterol inhaled

    use alternative or monitor BP, COPD sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • ozanimod
  • Coreg (carvedilol)
    +
    ozanimod
    1 interaction

    Avoid/Use Alternative

    carvedilol + ozanimod

    use alternative or monitor BP, HR, ECG, especially when starting or restarting ozanimod tx: combo may incr. risk of PR interval prolongation, AV block, bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • pindolol
  • Coreg (carvedilol)
    +
    pindolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + pindolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • ponesimod
  • Coreg (carvedilol)
    +
    ponesimod
    1 interaction

    Avoid/Use Alternative

    carvedilol + ponesimod

    use alternative or monitor BP, HR, ECG, especially when starting or restarting ponesimod tx; hold carvedilol if resting HR <55: combo may incr. risk of PR interval prolongation, AV block, bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • pralsetinib
  • Coreg (carvedilol)
    +
    pralsetinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + pralsetinib

    use alternative or monitor BP, consider monitoring ECG, electrolytes and decr. pralsetinib dose as follows: if on pralsetinib 400 mg qd, decr. to 300 mg qd; if on pralsetinib 400 mg qd and also combined w/ strong CYP3A4 inhibitor: decr. to 200 mg qd; if on pralsetinib 300 mg qd, decr. to 200 mg qd; if on pralsetinib 200 mg qd, decr. to 100 mg qd: combo may incr. pralsetinib levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • propranolol
  • Coreg (carvedilol)
    +
    propranolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + propranolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • relugolix
  • Coreg (carvedilol)
    +
    relugolix
    1 interaction

    Avoid/Use Alternative

    carvedilol + relugolix

    PROSTATE CANCER: may hold relugolix if carvedilol tx up to 2wk; otherwise, use alternative or monitor ECG, electrolytes and admin. relugolix at least 6h before carvedilol; FIBROID-ASSOC. BLEEDING: use alternative or admin. relugolix at least 6h before carvedilol: combo may incr. relugolix levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (gut P-gp-mediated transport inhibited)

  • repotrectinib
  • Coreg (carvedilol)
    +
    repotrectinib
    1 interaction

    Avoid/Use Alternative

    carvedilol + repotrectinib

    avoid combo: combo may incr. repotrectinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • rivaroxaban
  • Coreg (carvedilol)
    +
    rivaroxaban
    1 interaction

    Avoid/Use Alternative

    carvedilol + rivaroxaban

    avoid combo if also combined w/ strong CYP3A4 inhibitor; use alternative if CrCl <80 and combined w/ moderate CYP3A4 inhibitor; otherwise, monitor bleeding s/sx: combo may incr. rivaroxaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • rivastigmine
  • Coreg (carvedilol)
    +
    rivastigmine
    1 interaction

    Avoid/Use Alternative

    carvedilol + rivastigmine

    avoid combo: combo may incr. risk of bradycardia (additive effects)

  • salmeterol inhaled
  • Coreg (carvedilol)
    +
    salmeterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + salmeterol inhaled

    use alternative or monitor BP, bronchospasm sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • siponimod
  • Coreg (carvedilol)
    +
    siponimod
    1 interaction

    Avoid/Use Alternative

    carvedilol + siponimod

    use alternative or monitor BP, HR, ECG, especially when starting or restarting siponimod tx; hold carvedilol if resting HR <50: combo may incr. risk of PR interval prolongation, AV block, bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • sirolimus albumin-bound
  • Coreg (carvedilol)
    +
    sirolimus albumin-bound
    1 interaction

    Avoid/Use Alternative

    carvedilol + sirolimus albumin-bound

    avoid combo: combo may incr. sirolimus albumin-bound levels, risk of serious infection, myelosuppression, bleeding (including life-threatening), other adverse effects (P-gp-mediated transport inhibited)

  • sotalol
  • Coreg (carvedilol)
    +
    sotalol
    1 interaction

    Avoid/Use Alternative

    carvedilol + sotalol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (additive effects, duplicate therapy)

  • talazoparib
  • Coreg (carvedilol)
    +
    talazoparib
    1 interaction

    Avoid/Use Alternative

    carvedilol + talazoparib

    BREAST CANCER: use alternative or decr. talazoparib dose to 0.75 mg qd; monitor CBC; PROSTATE CANCER: monitor CBC: combo may incr. talazoparib levels, risk of myelosuppression, other adverse effects (P-gp-mediated transport inhibited)

  • terbutaline
  • Coreg (carvedilol)
    +
    terbutaline
    1 interaction

    Avoid/Use Alternative

    carvedilol + terbutaline

    use alternative or monitor BP, bronchospasm sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

  • timolol
  • Coreg (carvedilol)
    +
    timolol
    1 interaction

    Avoid/Use Alternative

    carvedilol + timolol

    avoid combo: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects, duplicate therapy)

  • topotecan
  • Coreg (carvedilol)
    +
    topotecan
    1 interaction

    Avoid/Use Alternative

    carvedilol + topotecan

    avoid combo w/ oral topotecan: combo may incr. topotecan levels, risk of serious infection, myelosuppression, other adverse effects (gut P-gp-mediated transport inhibited)

  • venetoclax
  • Coreg (carvedilol)
    +
    venetoclax
    1 interaction

    Avoid/Use Alternative

    carvedilol + venetoclax

    monitor CBC, tumor lysis syndrome s/sx; CLL/SLL: consider alternative or decr. venetoclax dose by at least 50%; AML: decr. venetoclax dose by at least 50%: combo may incr. venetoclax levels, risk of serious infection, myelosuppression, tumor lysis syndrome, other adverse effects (P-gp-mediated transport inhibited)

  • vilanterol inhaled
  • Coreg (carvedilol)
    +
    vilanterol inhaled
    1 interaction

    Avoid/Use Alternative

    carvedilol + vilanterol inhaled

    use alternative or monitor BP, bronchospasm sx; consider cardioselective beta blocker: combo may decr. efficacy of both drugs (antagonistic effects)

Monitor/Modify Tx

  • abiraterone acetate
  • Coreg (carvedilol)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    carvedilol + abiraterone acetate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • acarbose
  • Coreg (carvedilol)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    carvedilol + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • adagrasib
  • Coreg (carvedilol)
    +
    adagrasib
    1 interaction

    Monitor/Modify Tx

    carvedilol + adagrasib

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • adenosine
  • Coreg (carvedilol)
    +
    adenosine
    1 interaction

    Monitor/Modify Tx

    carvedilol + adenosine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • afatinib
  • Coreg (carvedilol)
    +
    afatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + afatinib

    decr. afatinib dose by 10 mg/day if not tolerated: combo may incr. afatinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • alectinib
  • Coreg (carvedilol)
    +
    alectinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + alectinib

    monitor HR: combo may incr. risk of bradycardia (additive effects)

  • alfentanil
  • Coreg (carvedilol)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    carvedilol + alfentanil

    monitor BP, HR: combo may incr. risk of bradycardia, severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Coreg (carvedilol)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    carvedilol + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • almotriptan
  • Coreg (carvedilol)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + almotriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • alogliptin
  • Coreg (carvedilol)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    carvedilol + alogliptin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • alprostadil intracavernous
  • Coreg (carvedilol)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    carvedilol + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension (additive effects)

  • amantadine
  • Coreg (carvedilol)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    carvedilol + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Coreg (carvedilol)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    carvedilol + amifostine

    D/C carvedilol 24h before amifostine admin.; monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • amiodarone
  • Coreg (carvedilol)
    +
    amiodarone
    1 interaction

    Monitor/Modify Tx

    carvedilol + amiodarone

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, sinus arrest, other adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited, additive effects)

  • amitriptyline
  • Coreg (carvedilol)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    carvedilol + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Coreg (carvedilol)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amphetamine
  • Coreg (carvedilol)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + amphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • apalutamide
  • Coreg (carvedilol)
    +
    apalutamide
    1 interaction

    Monitor/Modify Tx

    carvedilol + apalutamide

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport induced)

  • apomorphine
  • Coreg (carvedilol)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    carvedilol + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Coreg (carvedilol)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + apraclonidine ophthalmic

    monitor BP, HR if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension, bradycardia (additive effects)

  • aripiprazole bimonthly injection
  • Coreg (carvedilol)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole monthly injection
  • Coreg (carvedilol)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Coreg (carvedilol)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    carvedilol + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • armodafinil
  • Coreg (carvedilol)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    carvedilol + armodafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arsenic trioxide
  • Coreg (carvedilol)
    +
    arsenic trioxide
    1 interaction

    Monitor/Modify Tx

    carvedilol + arsenic trioxide

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • articaine
  • Coreg (carvedilol)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + articaine

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • asciminib
  • Coreg (carvedilol)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    carvedilol + asciminib

    monitor BP, HR, especially if asciminib 200 mg bid: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)

  • asenapine
  • Coreg (carvedilol)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aspirin
  • Coreg (carvedilol)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    carvedilol + aspirin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atazanavir
  • Coreg (carvedilol)
    +
    atazanavir
    1 interaction

    Monitor/Modify Tx

    carvedilol + atazanavir

    monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • atogepant
  • Coreg (carvedilol)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    carvedilol + atogepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Coreg (carvedilol)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    carvedilol + atomoxetine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atorvastatin
  • Coreg (carvedilol)
    +
    atorvastatin
    1 interaction

    Monitor/Modify Tx

    carvedilol + atorvastatin

    monitor CK, myopathy sx: combo may incr. atorvastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited)

  • atropine ophthalmic
  • Coreg (carvedilol)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + atropine ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • avanafil
  • Coreg (carvedilol)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    carvedilol + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • avatrombopag
  • Coreg (carvedilol)
    +
    avatrombopag
    1 interaction

    Monitor/Modify Tx

    carvedilol + avatrombopag

    monitor platelets, thrombosis s/sx: combo may incr. avatrombopag levels, risk of thromboembolism, other adverse effects (P-gp-mediated transport inhibited)

  • axitinib
  • Coreg (carvedilol)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + axitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • azithromycin
  • Coreg (carvedilol)
    +
    azithromycin
    1 interaction

    Monitor/Modify Tx

    carvedilol + azithromycin

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • belumosudil
  • Coreg (carvedilol)
    +
    belumosudil
    1 interaction

    Monitor/Modify Tx

    carvedilol + belumosudil

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • benzphetamine
  • Coreg (carvedilol)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + benzphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • berberine
  • Coreg (carvedilol)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    carvedilol + berberine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • betamethasone
  • Coreg (carvedilol)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    carvedilol + betamethasone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • betaxolol ophthalmic
  • Coreg (carvedilol)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + betaxolol ophthalmic

    monitor BP, HR, IOP: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, excessively decr. IOP (additive effects)

  • bethanechol
  • Coreg (carvedilol)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    carvedilol + bethanechol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • bevacizumab
  • Coreg (carvedilol)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + bevacizumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bexagliflozin
  • Coreg (carvedilol)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + bexagliflozin

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects; antagonistic effects)

  • bismuth subsalicylate
  • Coreg (carvedilol)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    carvedilol + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bortezomib
  • Coreg (carvedilol)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    carvedilol + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brexpiprazole
  • Coreg (carvedilol)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    carvedilol + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brimonidine ophthalmic
  • Coreg (carvedilol)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension (additive effects)

  • brimonidine topical
  • Coreg (carvedilol)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    carvedilol + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Coreg (carvedilol)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    carvedilol + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia, hypotension, including orthostasis, syncope (additive effects; antagonistic effects)

  • budesonide
  • Coreg (carvedilol)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    carvedilol + budesonide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupivacaine
  • Coreg (carvedilol)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + bupivacaine

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • bupivacaine liposomal
  • Coreg (carvedilol)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    carvedilol + bupivacaine liposomal

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • buprenorphine
  • Coreg (carvedilol)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    carvedilol + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • bupropion
  • Coreg (carvedilol)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    carvedilol + bupropion

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)

  • butorphanol
  • Coreg (carvedilol)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    carvedilol + butorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Coreg (carvedilol)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    carvedilol + cabergoline

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • cabozantinib
  • Coreg (carvedilol)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + cabozantinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine
  • Coreg (carvedilol)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    carvedilol + caffeine

    monitor BP; avoid excessive caffeine intake: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caffeine citrate
  • Coreg (carvedilol)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    carvedilol + caffeine citrate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • canagliflozin
  • Coreg (carvedilol)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + canagliflozin

    monitor BP, glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia, hypotension, including orthostasis, syncope (additive effects, antagonistic effects)

  • cannabidiol
  • Coreg (carvedilol)
    +
    cannabidiol
    1 interaction

    Monitor/Modify Tx

    carvedilol + cannabidiol

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (gut P-gp-mediated transport inhibited)

  • cannabis
  • Coreg (carvedilol)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    carvedilol + cannabis

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • carbamazepine
  • Coreg (carvedilol)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    carvedilol + carbamazepine

    monitor BP, HR: combo may decr. carvedilol levels, efficacy; may incr. risk of PR interval prolongation, AV block, bradycardia (P-gp-mediated transport induced; additive effects)

  • carfilzomib
  • Coreg (carvedilol)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    carvedilol + carfilzomib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cariprazine
  • Coreg (carvedilol)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Coreg (carvedilol)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + carteolol ophthalmic

    monitor BP, HR, IOP: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, excessively decr. IOP (additive effects)

  • celecoxib
  • Coreg (carvedilol)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    carvedilol + celecoxib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chloroprocaine
  • Coreg (carvedilol)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + chloroprocaine

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • chlorpromazine
  • Coreg (carvedilol)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cilostazol
  • Coreg (carvedilol)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    carvedilol + cilostazol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • cinacalcet
  • Coreg (carvedilol)
    +
    cinacalcet
    1 interaction

    Monitor/Modify Tx

    carvedilol + cinacalcet

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • clarithromycin
  • Coreg (carvedilol)
    +
    clarithromycin
    1 interaction

    Monitor/Modify Tx

    carvedilol + clarithromycin

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • clofarabine
  • Coreg (carvedilol)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    carvedilol + clofarabine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • clomipramine
  • Coreg (carvedilol)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    carvedilol + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Coreg (carvedilol)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + clozapine

    monitor BP, HR: combo may incr. risk of severe bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • cobicistat
  • Coreg (carvedilol)
    +
    cobicistat
    1 interaction

    Monitor/Modify Tx

    carvedilol + cobicistat

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • cocaine
  • Coreg (carvedilol)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + cocaine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • codeine
  • Coreg (carvedilol)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    carvedilol + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Coreg (carvedilol)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    carvedilol + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • colesevelam
  • Coreg (carvedilol)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    carvedilol + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • copanlisib
  • Coreg (carvedilol)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    carvedilol + copanlisib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Coreg (carvedilol)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    carvedilol + corticotropin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cortisone
  • Coreg (carvedilol)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    carvedilol + cortisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cyclosporine
  • Coreg (carvedilol)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    carvedilol + cyclosporine

    monitor cyclosporine levels, renal fxn, BP, HR: combo may incr. levels of both drugs, risk of hypotension, bradycardia, AV block, serious infection, nephrotoxicity, other adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • dacomitinib
  • Coreg (carvedilol)
    +
    dacomitinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + dacomitinib

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • danazol
  • Coreg (carvedilol)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    carvedilol + danazol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • danicopan
  • Coreg (carvedilol)
    +
    danicopan
    1 interaction

    Monitor/Modify Tx

    carvedilol + danicopan

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • danshen
  • Coreg (carvedilol)
    +
    danshen
    1 interaction

    Monitor/Modify Tx

    carvedilol + danshen

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport induced)

  • dapagliflozin
  • Coreg (carvedilol)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + dapagliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • darbepoetin alfa
  • Coreg (carvedilol)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    carvedilol + darbepoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • darunavir
  • Coreg (carvedilol)
    +
    darunavir
    1 interaction

    Monitor/Modify Tx

    carvedilol + darunavir

    monitor BP, HR; consider carvedilol dose decr.: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • deflazacort
  • Coreg (carvedilol)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    carvedilol + deflazacort

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • denileukin diftitox
  • Coreg (carvedilol)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    carvedilol + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Coreg (carvedilol)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    carvedilol + desflurane

    monitor BP; use for therapeutic advantage to decr BP during surgery: combo may cause prolonged hypotension, decr. cardiac output, other myocardial depressant effects (additive/synergistic effects)

  • desipramine
  • Coreg (carvedilol)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    carvedilol + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desmopressin
  • Coreg (carvedilol)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    carvedilol + desmopressin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • desvenlafaxine
  • Coreg (carvedilol)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    carvedilol + desvenlafaxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dexamethasone
  • Coreg (carvedilol)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    carvedilol + dexamethasone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dexmedetomidine
  • Coreg (carvedilol)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    carvedilol + dexmedetomidine

    monitor BP, HR: combo may incr. risk of bradycardia, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Coreg (carvedilol)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + dexmedetomidine injection

    monitor BP, HR: combo may incr. risk of severe or life-threatening hypotension, bradycardia (additive effects)

  • dexmethylphenidate
  • Coreg (carvedilol)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    carvedilol + dexmethylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dextroamphetamine
  • Coreg (carvedilol)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + dextroamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diazoxide
  • Coreg (carvedilol)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    carvedilol + diazoxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • diclofenac
  • Coreg (carvedilol)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    carvedilol + diclofenac

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diclofenac topical
  • Coreg (carvedilol)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    carvedilol + diclofenac topical

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dicloxacillin
  • Coreg (carvedilol)
    +
    dicloxacillin
    1 interaction

    Monitor/Modify Tx

    carvedilol + dicloxacillin

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport induced)

  • diethylpropion
  • Coreg (carvedilol)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    carvedilol + diethylpropion

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diflunisal
  • Coreg (carvedilol)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    carvedilol + diflunisal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • digoxin
  • Coreg (carvedilol)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    carvedilol + digoxin

    monitor digoxin levels, HR; decr. digoxin frequency or dose by 15-30%: combo may incr. digoxin levels, risk of PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • dihydrocodeine
  • Coreg (carvedilol)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    carvedilol + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • dihydroergotamine
  • Coreg (carvedilol)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + dihydroergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • diltiazem
  • Coreg (carvedilol)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    carvedilol + diltiazem

    monitor ECG, BP, HR: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia (additive effects)

  • dinutuximab
  • Coreg (carvedilol)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    carvedilol + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • diosmin
  • Coreg (carvedilol)
    +
    diosmin
    1 interaction

    Monitor/Modify Tx

    carvedilol + diosmin

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • dipyridamole
  • Coreg (carvedilol)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    carvedilol + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • disopyramide
  • Coreg (carvedilol)
    +
    disopyramide
    1 interaction

    Monitor/Modify Tx

    carvedilol + disopyramide

    monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • dobutamine
  • Coreg (carvedilol)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + dobutamine

    monitor BP, HR: combo may decr. efficacy of both drugs (antagonistic effects)

  • donepezil
  • Coreg (carvedilol)
    +
    donepezil
    1 interaction

    Monitor/Modify Tx

    carvedilol + donepezil

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia, bronchospasm (additive effects)

  • dopamine
  • Coreg (carvedilol)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + dopamine

    monitor BP, HR, especially w/ dopamine doses >5 mcg/kg/minute: combo may decr. efficacy of both drugs (antagonistic effects)

  • doxapram
  • Coreg (carvedilol)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    carvedilol + doxapram

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxazosin
  • Coreg (carvedilol)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    carvedilol + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Coreg (carvedilol)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    carvedilol + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dronabinol
  • Coreg (carvedilol)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    carvedilol + dronabinol

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • dronedarone
  • Coreg (carvedilol)
    +
    dronedarone
    1 interaction

    Monitor/Modify Tx

    carvedilol + dronedarone

    start w/ low carvedilol dose; monitor BP, HR, ECG: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • droxidopa
  • Coreg (carvedilol)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    carvedilol + droxidopa

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • dulaglutide
  • Coreg (carvedilol)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    carvedilol + dulaglutide

    monitor HR, glucose: combo may incr. risk of PR interval prolongation, AV block, bradycardia; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • duloxetine
  • Coreg (carvedilol)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    carvedilol + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • edoxaban
  • Coreg (carvedilol)
    +
    edoxaban
    1 interaction

    Monitor/Modify Tx

    carvedilol + edoxaban

    monitor bleeding s/sx; decr. edoxaban dose to 30 mg/day in DVT/PE pts; no dose adjustment recommended in atrial fibrillation pts: combo may incr. edoxaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • efavirenz
  • Coreg (carvedilol)
    +
    efavirenz
    1 interaction

    Monitor/Modify Tx

    carvedilol + efavirenz

    monitor BP, HR: combo may incr. or decr. carvedilol levels, incr. risk of hypotension, bradycardia, AV block, other adverse effects or decr. efficacy (hepatic metabolism inhibited; P-gp-mediated transport induced)

  • eletriptan
  • Coreg (carvedilol)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + eletriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • eliglustat
  • Coreg (carvedilol)
    +
    eliglustat
    1 interaction

    Monitor/Modify Tx

    carvedilol + eliglustat

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • empagliflozin
  • Coreg (carvedilol)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + empagliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis (antagonistic effects; additive effects)

  • enfortumab vedotin
  • Coreg (carvedilol)
    +
    enfortumab vedotin
    1 interaction

    Monitor/Modify Tx

    carvedilol + enfortumab vedotin

    if also combined w/ strong CYP3A4 inhibitor, monitor CBC, glucose: combo may incr. enfortumab vedotin levels, risk of myelosuppression, neuropathy, hyperglycemia, other adverse effects (P-gp-mediated transport inhibited)

  • entacapone
  • Coreg (carvedilol)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    carvedilol + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Coreg (carvedilol)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + entrectinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • enzalutamide
  • Coreg (carvedilol)
    +
    enzalutamide
    1 interaction

    Monitor/Modify Tx

    carvedilol + enzalutamide

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (hepatic metabolism induced)

  • ephedra
  • Coreg (carvedilol)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    carvedilol + ephedra

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Coreg (carvedilol)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + ephedrine injection

    monitor BP: combo may decr. pressor response; may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine oral
  • Coreg (carvedilol)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    carvedilol + ephedrine oral

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epinephrine inhaled
  • Coreg (carvedilol)
    +
    epinephrine inhaled
    1 interaction

    Monitor/Modify Tx

    carvedilol + epinephrine inhaled

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • epoetin alfa
  • Coreg (carvedilol)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    carvedilol + epoetin alfa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoprostenol
  • Coreg (carvedilol)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    carvedilol + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • eptinezumab
  • Coreg (carvedilol)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + eptinezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • erenumab
  • Coreg (carvedilol)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + erenumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ergotamine
  • Coreg (carvedilol)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + ergotamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ertugliflozin
  • Coreg (carvedilol)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + ertugliflozin

    monitor glucose, BP: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia, hypotension, including orthostasis (antagonistic effects, additive effects)

  • erythromycin
  • Coreg (carvedilol)
    +
    erythromycin
    1 interaction

    Monitor/Modify Tx

    carvedilol + erythromycin

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • esketamine
  • Coreg (carvedilol)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + esketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Coreg (carvedilol)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    carvedilol + estetrol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Coreg (carvedilol)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    carvedilol + estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Coreg (carvedilol)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    carvedilol + ethanol (alcoholic beverage)

    monitor BP: combo may alter BP control, initially incr. risk of severe hypotension, followed by HTN (additive effects, antagonistic effects, acute alcohol intake may have biphasic effects on blood pressure; chronic alcohol use may further increase HTN risk)

  • ethanol injection
  • Coreg (carvedilol)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • ethinyl estradiol (contraceptive)
  • Coreg (carvedilol)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    carvedilol + ethinyl estradiol (contraceptive)

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • etodolac
  • Coreg (carvedilol)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    carvedilol + etodolac

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • everolimus
  • Coreg (carvedilol)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    carvedilol + everolimus

    TSC-ASSOC. SEGA, TSC-ASSOC. PARTIAL ONSET SEIZURES, TRANSPLANT: monitor everolimus levels, CBC; OTHER INDICATIONS: monitor CBC: combo may incr. everolimus levels, risk of serious infection, myelosuppression, other adverse effects (P-gp-mediated transport inhibited)

  • exenatide
  • Coreg (carvedilol)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    carvedilol + exenatide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • fenfluramine
  • Coreg (carvedilol)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    carvedilol + fenfluramine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Coreg (carvedilol)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    carvedilol + fenoprofen

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fentanyl
  • Coreg (carvedilol)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    carvedilol + fentanyl

    monitor BP, HR: combo may incr. risk of bradycardia, severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Coreg (carvedilol)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    carvedilol + ferumoxytol

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flaxseed
  • Coreg (carvedilol)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    carvedilol + flaxseed

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • flecainide
  • Coreg (carvedilol)
    +
    flecainide
    1 interaction

    Monitor/Modify Tx

    carvedilol + flecainide

    monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • flibanserin
  • Coreg (carvedilol)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    carvedilol + flibanserin

    monitor BP, HR: combo may incr. carvedilol levels, risk of severe hypotension (including syncope), bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • fluconazole
  • Coreg (carvedilol)
    +
    fluconazole
    1 interaction

    Monitor/Modify Tx

    carvedilol + fluconazole

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • fludrocortisone
  • Coreg (carvedilol)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    carvedilol + fludrocortisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fluorouracil
  • Coreg (carvedilol)
    +
    fluorouracil
    1 interaction

    Monitor/Modify Tx

    carvedilol + fluorouracil

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • fluoxetine
  • Coreg (carvedilol)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    carvedilol + fluoxetine

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • fluphenazine
  • Coreg (carvedilol)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flurbiprofen
  • Coreg (carvedilol)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    carvedilol + flurbiprofen

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • foslevodopa
  • Coreg (carvedilol)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    carvedilol + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fosphenytoin
  • Coreg (carvedilol)
    +
    fosphenytoin
    1 interaction

    Monitor/Modify Tx

    carvedilol + fosphenytoin

    monitor BP, HR: combo may decr. carvedilol levels, efficacy; may incr. risk of PR interval prolongation, AV block, bradycardia (P-gp-mediated transport induced; additive effects)

  • fostamatinib
  • Coreg (carvedilol)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + fostamatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fremanezumab
  • Coreg (carvedilol)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + fremanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • frovatriptan
  • Coreg (carvedilol)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + frovatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fruquintinib
  • Coreg (carvedilol)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + fruquintinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • gadobenate dimeglumine
  • Coreg (carvedilol)
    +
    gadobenate dimeglumine
    1 interaction

    Monitor/Modify Tx

    carvedilol + gadobenate dimeglumine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • galantamine
  • Coreg (carvedilol)
    +
    galantamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + galantamine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • galcanezumab
  • Coreg (carvedilol)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + galcanezumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • garlic
  • Coreg (carvedilol)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    carvedilol + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension (additive effects)

  • gilteritinib
  • Coreg (carvedilol)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + gilteritinib

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • glecaprevir
  • Coreg (carvedilol)
    +
    glecaprevir
    1 interaction

    Monitor/Modify Tx

    carvedilol + glecaprevir

    monitor BP, HR: combo may incr. levels of both drugs, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • glimepiride
  • Coreg (carvedilol)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    carvedilol + glimepiride

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • glipizide
  • Coreg (carvedilol)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    carvedilol + glipizide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • glyburide
  • Coreg (carvedilol)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    carvedilol + glyburide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • guanfacine
  • Coreg (carvedilol)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    carvedilol + guanfacine

    monitor BP, HR; D/C beta blocker prior to guanfacine taper: combo may incr. risk of hypotension (including orthostasis), PR interval prolongation, AV block, bradycardia, severe rebound HTN on alpha-2 agonist withdrawal (additive effects; antagonistic effects, unopposed alpha adrenergic stimulation)

  • haloperidol
  • Coreg (carvedilol)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    carvedilol + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hoodia
  • Coreg (carvedilol)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    carvedilol + hoodia

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydralazine
  • Coreg (carvedilol)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + hydralazine

    monitor BP: combo may incr. risk of severe hypotension (additive effects)

  • hydrocodone
  • Coreg (carvedilol)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    carvedilol + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydrocortisone
  • Coreg (carvedilol)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    carvedilol + hydrocortisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydromorphone
  • Coreg (carvedilol)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    carvedilol + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxocobalamin IV
  • Coreg (carvedilol)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    carvedilol + hydroxocobalamin IV

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibrutinib
  • Coreg (carvedilol)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + ibrutinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ibuprofen
  • Coreg (carvedilol)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    carvedilol + ibuprofen

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • iloperidone
  • Coreg (carvedilol)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Coreg (carvedilol)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    carvedilol + iloprost

    monitor BP; consider holding carvedilol during iloprost admin.: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Coreg (carvedilol)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    carvedilol + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • indomethacin
  • Coreg (carvedilol)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    carvedilol + indomethacin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • insulin
  • Coreg (carvedilol)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    carvedilol + insulin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • iron sucrose
  • Coreg (carvedilol)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    carvedilol + iron sucrose

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • isoflurane
  • Coreg (carvedilol)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    carvedilol + isoflurane

    monitor BP; use for therapeutic advantage to decr. BP during surgery: combo may cause prolonged hypotension, decr. cardiac output, other myocardial depressant effects (additive effects)

  • isoproterenol
  • Coreg (carvedilol)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    carvedilol + isoproterenol

    monitor BP, HR: combo may decr. efficacy of both drugs (antagonistic effects)

  • isosorbide dinitrate
  • Coreg (carvedilol)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    carvedilol + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • isosorbide mononitrate
  • Coreg (carvedilol)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    carvedilol + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • itraconazole
  • Coreg (carvedilol)
    +
    itraconazole
    1 interaction

    Monitor/Modify Tx

    carvedilol + itraconazole

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • ivabradine
  • Coreg (carvedilol)
    +
    ivabradine
    1 interaction

    Monitor/Modify Tx

    carvedilol + ivabradine

    monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • ketamine
  • Coreg (carvedilol)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + ketamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketoconazole
  • Coreg (carvedilol)
    +
    ketoconazole
    1 interaction

    Monitor/Modify Tx

    carvedilol + ketoconazole

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • ketoprofen
  • Coreg (carvedilol)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    carvedilol + ketoprofen

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketorolac
  • Coreg (carvedilol)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    carvedilol + ketorolac

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lacosamide
  • Coreg (carvedilol)
    +
    lacosamide
    1 interaction

    Monitor/Modify Tx

    carvedilol + lacosamide

    monitor HR, ECG, especially during lacosamide initiation/titration: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • lamotrigine
  • Coreg (carvedilol)
    +
    lamotrigine
    1 interaction

    Monitor/Modify Tx

    carvedilol + lamotrigine

    monitor HR: combo may incr. risk of bradycardia (additive effects)

  • lanreotide
  • Coreg (carvedilol)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    carvedilol + lanreotide

    monitor BP, HR; consider lower beta blocker dose: combo may incr. risk of bradycardia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • lapatinib
  • Coreg (carvedilol)
    +
    lapatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + lapatinib

    monitor BP, HR, ECG: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • ledipasvir
  • Coreg (carvedilol)
    +
    ledipasvir
    1 interaction

    Monitor/Modify Tx

    carvedilol + ledipasvir

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (gut P-gp-mediated transport inhibited)

  • lefamulin
  • Coreg (carvedilol)
    +
    lefamulin
    1 interaction

    Monitor/Modify Tx

    carvedilol + lefamulin

    ORAL LEFAMULIN: monitor ECG; IV lefamulin use OK: combo may incr. lefamulin levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (P-gp-mediated transport inhibited)

  • leflunomide
  • Coreg (carvedilol)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    carvedilol + leflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lenvatinib
  • Coreg (carvedilol)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + lenvatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • levobunolol ophthalmic
  • Coreg (carvedilol)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + levobunolol ophthalmic

    monitor BP, HR, IOP: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, excessively decr. IOP (additive effects)

  • levodopa
  • Coreg (carvedilol)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    carvedilol + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levoketoconazole
  • Coreg (carvedilol)
    +
    levoketoconazole
    1 interaction

    Monitor/Modify Tx

    carvedilol + levoketoconazole

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • levomilnacipran
  • Coreg (carvedilol)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    carvedilol + levomilnacipran

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • levorphanol
  • Coreg (carvedilol)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    carvedilol + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • levothyroxine
  • Coreg (carvedilol)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    carvedilol + levothyroxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • licorice
  • Coreg (carvedilol)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    carvedilol + licorice

    monitor BP w/ large amounts of licorice: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lidocaine
  • Coreg (carvedilol)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + lidocaine

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • linagliptin
  • Coreg (carvedilol)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    carvedilol + linagliptin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • liothyronine
  • Coreg (carvedilol)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    carvedilol + liothyronine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • liraglutide
  • Coreg (carvedilol)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    carvedilol + liraglutide

    monitor glucose in type 2 diabetes mellitus pts, consider monitoring glucose in obesity pts: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • lisdexamfetamine
  • Coreg (carvedilol)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + lisdexamfetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lixisenatide
  • Coreg (carvedilol)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    carvedilol + lixisenatide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • lopinavir/ritonavir
  • Coreg (carvedilol)
    +
    lopinavir/ ritonavir
    1 interaction

    Monitor/Modify Tx

    carvedilol + lopinavir/ ritonavir

    monitor BP, HR, ECG: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • lorlatinib
  • Coreg (carvedilol)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + lorlatinib

    monitor BP, HR, ECG: combo may decr. carvedilol levels, efficacy; may incr. risk of PR interval prolongation, AV block, bradycardia (P-gp-mediated transport induced, antagonistic effects; additive effects)

  • lovastatin
  • Coreg (carvedilol)
    +
    lovastatin
    1 interaction

    Monitor/Modify Tx

    carvedilol + lovastatin

    monitor CK, myopathy sx: combo may incr. lovastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited)

  • loxapine
  • Coreg (carvedilol)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Coreg (carvedilol)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    carvedilol + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including syncope (additive effects)

  • lumacaftor/ivacaftor
  • Coreg (carvedilol)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    carvedilol + lumacaftor/ ivacaftor

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced, antagonistic effects)

  • lumateperone
  • Coreg (carvedilol)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    carvedilol + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Coreg (carvedilol)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • luspatercept
  • Coreg (carvedilol)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    carvedilol + luspatercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • magnesium salicylate
  • Coreg (carvedilol)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    carvedilol + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • magnesium sulfate
  • Coreg (carvedilol)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    carvedilol + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • maraviroc
  • Coreg (carvedilol)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    carvedilol + maraviroc

    monitor BP: combo may incr. maraviroc levels, risk of hypotension (including orthostasis), other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • mavacamten
  • Coreg (carvedilol)
    +
    mavacamten
    1 interaction

    Monitor/Modify Tx

    carvedilol + mavacamten

    monitor BP, HR, cardiac fxn incl. LVEF, especially during carvedilol initiation/titration: combo may decr. carvedilol levels, efficacy; may incr. risk of left ventricular systolic dysfunction, heart failure symptoms (hepatic metabolism induced; additive negative inotropic effects)

  • mavorixafor
  • Coreg (carvedilol)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    carvedilol + mavorixafor

    monitor ECG, BP, HR: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • meclofenamate
  • Coreg (carvedilol)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    carvedilol + meclofenamate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mefenamic acid
  • Coreg (carvedilol)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    carvedilol + mefenamic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mefloquine
  • Coreg (carvedilol)
    +
    mefloquine
    1 interaction

    Monitor/Modify Tx

    carvedilol + mefloquine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • meloxicam
  • Coreg (carvedilol)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    carvedilol + meloxicam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • meperidine
  • Coreg (carvedilol)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    carvedilol + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Coreg (carvedilol)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + mepivacaine

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • meropenem
  • Coreg (carvedilol)
    +
    meropenem
    1 interaction

    Monitor/Modify Tx

    carvedilol + meropenem

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced)

  • methadone
  • Coreg (carvedilol)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    carvedilol + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methamphetamine
  • Coreg (carvedilol)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    carvedilol + methamphetamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methohexital
  • Coreg (carvedilol)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    carvedilol + methohexital

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Coreg (carvedilol)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    carvedilol + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylene blue injection
  • Coreg (carvedilol)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylergonovine
  • Coreg (carvedilol)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    carvedilol + methylergonovine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylphenidate
  • Coreg (carvedilol)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    carvedilol + methylphenidate

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylprednisolone
  • Coreg (carvedilol)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    carvedilol + methylprednisolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methyltestosterone
  • Coreg (carvedilol)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    carvedilol + methyltestosterone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoclopramide
  • Coreg (carvedilol)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    carvedilol + metoclopramide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • midazolam
  • Coreg (carvedilol)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    carvedilol + midazolam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • midodrine
  • Coreg (carvedilol)
    +
    midodrine
    1 interaction

    Monitor/Modify Tx

    carvedilol + midodrine

    monitor BP, HR: combo may decr. efficacy of both drugs; may incr. risk of bradycardia (antagonistic effects; additive effects)

  • miglitol
  • Coreg (carvedilol)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    carvedilol + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milk thistle
  • Coreg (carvedilol)
    +
    milk thistle
    1 interaction

    Monitor/Modify Tx

    carvedilol + milk thistle

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • milnacipran
  • Coreg (carvedilol)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    carvedilol + milnacipran

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milrinone
  • Coreg (carvedilol)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    carvedilol + milrinone

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • milsaperidone
  • Coreg (carvedilol)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mirabegron
  • Coreg (carvedilol)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    carvedilol + mirabegron

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirtazapine
  • Coreg (carvedilol)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • modafinil
  • Coreg (carvedilol)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    carvedilol + modafinil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • molindone
  • Coreg (carvedilol)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    carvedilol + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • morphine
  • Coreg (carvedilol)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    carvedilol + morphine

    monitor respiratory rate, BP; consider decr. dose of one or both drugs: combo may incr. morphine levels, risk of CNS and respiratory depression, psychomotor impairment, severe hypotension (including orthostasis, syncope), other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • nabumetone
  • Coreg (carvedilol)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    carvedilol + nabumetone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nalbuphine
  • Coreg (carvedilol)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    carvedilol + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • naphazoline ophthalmic
  • Coreg (carvedilol)
    +
    naphazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + naphazoline ophthalmic

    consider monitoring BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • naproxen
  • Coreg (carvedilol)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    carvedilol + naproxen

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naratriptan
  • Coreg (carvedilol)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + naratriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nateglinide
  • Coreg (carvedilol)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    carvedilol + nateglinide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • nattokinase
  • Coreg (carvedilol)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    carvedilol + nattokinase

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • naxitamab
  • Coreg (carvedilol)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    carvedilol + naxitamab

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • neostigmine
  • Coreg (carvedilol)
    +
    neostigmine
    1 interaction

    Monitor/Modify Tx

    carvedilol + neostigmine

    monitor HR: combo may incr. risk of bradycardia (additive effects)

  • niacin (vitamin B3)
  • Coreg (carvedilol)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    carvedilol + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • niraparib
  • Coreg (carvedilol)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    carvedilol + niraparib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nitisinone
  • Coreg (carvedilol)
    +
    nitisinone
    1 interaction

    Monitor/Modify Tx

    carvedilol + nitisinone

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • nitric oxide
  • Coreg (carvedilol)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    carvedilol + nitric oxide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • nitrite
  • Coreg (carvedilol)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    carvedilol + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including syncope (additive effects)

  • nitroglycerin
  • Coreg (carvedilol)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    carvedilol + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Coreg (carvedilol)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    carvedilol + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • nortriptyline
  • Coreg (carvedilol)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    carvedilol + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Coreg (carvedilol)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + obinutuzumab

    monitor BP: combo may incr. risk of hypotension; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • octreotide
  • Coreg (carvedilol)
    +
    octreotide
    1 interaction

    Monitor/Modify Tx

    carvedilol + octreotide

    monitor HR; consider lower beta blocker dose: combo may incr. risk of bradycardia (additive effects)

  • olanzapine
  • Coreg (carvedilol)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Coreg (carvedilol)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    carvedilol + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • opicapone
  • Coreg (carvedilol)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    carvedilol + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Coreg (carvedilol)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    carvedilol + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • osilodrostat
  • Coreg (carvedilol)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    carvedilol + osilodrostat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxaprozin
  • Coreg (carvedilol)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxaprozin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxazepam
  • Coreg (carvedilol)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxazepam

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • oxcarbazepine
  • Coreg (carvedilol)
    +
    oxcarbazepine
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxcarbazepine

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced)

  • oxycodone
  • Coreg (carvedilol)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxymetazoline nasal
  • Coreg (carvedilol)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxymetazoline nasal

    monitor BP: may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline ophthalmic
  • Coreg (carvedilol)
    +
    oxymetazoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxymetazoline ophthalmic

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymetazoline topical
  • Coreg (carvedilol)
    +
    oxymetazoline topical
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxymetazoline topical

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • oxymorphone
  • Coreg (carvedilol)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxytocin
  • Coreg (carvedilol)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    carvedilol + oxytocin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • paliperidone
  • Coreg (carvedilol)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Coreg (carvedilol)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    carvedilol + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • paltusotine
  • Coreg (carvedilol)
    +
    paltusotine
    1 interaction

    Monitor/Modify Tx

    carvedilol + paltusotine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • paroxetine
  • Coreg (carvedilol)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    carvedilol + paroxetine

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • pasireotide
  • Coreg (carvedilol)
    +
    pasireotide
    1 interaction

    Monitor/Modify Tx

    carvedilol + pasireotide

    monitor HR; consider lower beta blocker dose: combo may incr. risk of bradycardia (additive effects; antagonistic effects)

  • patiromer
  • Coreg (carvedilol)
    +
    patiromer
    1 interaction

    Monitor/Modify Tx

    carvedilol + patiromer

    separate admin. by >3h: combo may decr. carvedilol levels, efficacy (absorption decreased)

  • pazopanib
  • Coreg (carvedilol)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    carvedilol + pazopanib

    monitor ECG, BP: combo may incr. pazopanib levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • pentamidine
  • Coreg (carvedilol)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    carvedilol + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension (additive effects)

  • pentazocine
  • Coreg (carvedilol)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    carvedilol + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Coreg (carvedilol)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    carvedilol + pentobarbital

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • pentoxifylline
  • Coreg (carvedilol)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    carvedilol + pentoxifylline

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • perphenazine
  • Coreg (carvedilol)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + perphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pexidartinib
  • Coreg (carvedilol)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + pexidartinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phendimetrazine
  • Coreg (carvedilol)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + phendimetrazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenelzine
  • Coreg (carvedilol)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Coreg (carvedilol)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenobarbital

    monitor BP, HR: combo may decr. carvedilol levels, efficacy; may incr. risk of hypotension, including orthostasis (P-gp-mediated transport possibly induced; additive effects)

  • phentermine
  • Coreg (carvedilol)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    carvedilol + phentermine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Coreg (carvedilol)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenylephrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine injection
  • Coreg (carvedilol)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenylephrine injection

    monitor BP, HR: combo may decr. efficacy of both drugs (antagonistic effects)

  • phenylephrine nasal
  • Coreg (carvedilol)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenylephrine nasal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine ophthalmic
  • Coreg (carvedilol)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine rectal
  • Coreg (carvedilol)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenylephrine rectal

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenytoin
  • Coreg (carvedilol)
    +
    phenytoin
    1 interaction

    Monitor/Modify Tx

    carvedilol + phenytoin

    monitor BP, HR: combo may decr. carvedilol levels, efficacy; may incr. risk of PR interval prolongation, AV block, bradycardia (P-gp-mediated transport induced; additive effects)

  • pibrentasvir
  • Coreg (carvedilol)
    +
    pibrentasvir
    1 interaction

    Monitor/Modify Tx

    carvedilol + pibrentasvir

    monitor BP, HR: combo may incr. levels of both drugs, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • pioglitazone
  • Coreg (carvedilol)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    carvedilol + pioglitazone

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • piroxicam
  • Coreg (carvedilol)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    carvedilol + piroxicam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pitavastatin
  • Coreg (carvedilol)
    +
    pitavastatin
    1 interaction

    Monitor/Modify Tx

    carvedilol + pitavastatin

    monitor CK, myopathy sx: combo may incr. pitavastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited)

  • ponatinib
  • Coreg (carvedilol)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + ponatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pramipexole
  • Coreg (carvedilol)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    carvedilol + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Coreg (carvedilol)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    carvedilol + pramlintide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • praziquantel
  • Coreg (carvedilol)
    +
    praziquantel
    1 interaction

    Monitor/Modify Tx

    carvedilol + praziquantel

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • prazosin
  • Coreg (carvedilol)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    carvedilol + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prednisolone
  • Coreg (carvedilol)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    carvedilol + prednisolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisone
  • Coreg (carvedilol)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    carvedilol + prednisone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • primidone
  • Coreg (carvedilol)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + primidone

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced)

  • procainamide
  • Coreg (carvedilol)
    +
    procainamide
    1 interaction

    Monitor/Modify Tx

    carvedilol + procainamide

    monitor HR, ECG: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • procarbazine
  • Coreg (carvedilol)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + procarbazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • prochlorperazine
  • Coreg (carvedilol)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Coreg (carvedilol)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + promethazine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • propafenone
  • Coreg (carvedilol)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    carvedilol + propafenone

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • propofol
  • Coreg (carvedilol)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    carvedilol + propofol

    monitor BP, HR: combo may incr. risk of severe hypotension, bradycardia (additive effects)

  • protriptyline
  • Coreg (carvedilol)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    carvedilol + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pseudoephedrine
  • Coreg (carvedilol)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    carvedilol + pseudoephedrine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pyridostigmine
  • Coreg (carvedilol)
    +
    pyridostigmine
    1 interaction

    Monitor/Modify Tx

    carvedilol + pyridostigmine

    monitor HR: combo may incr. risk of bradycardia (additive effects)

  • quetiapine
  • Coreg (carvedilol)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    carvedilol + quetiapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antihypertensive agent efficacy (peds patients) (additive effects, antagonistic effects)

  • quinidine (antiarrhythmic)
  • Coreg (carvedilol)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    carvedilol + quinidine (antiarrhythmic)

    monitor quinidine levels, ECG, BP, HR: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited, additive effects)

  • quinidine (CYP2D6 inhibitor)
  • Coreg (carvedilol)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    carvedilol + quinidine (CYP2D6 inhibitor)

    monitor ECG, BP, HR: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • quinine
  • Coreg (carvedilol)
    +
    quinine
    1 interaction

    Monitor/Modify Tx

    carvedilol + quinine

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • ramucirumab
  • Coreg (carvedilol)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    carvedilol + ramucirumab

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ranolazine
  • Coreg (carvedilol)
    +
    ranolazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + ranolazine

    monitor BP, HR, ECG: combo may incr. levels of both drugs, risk of QT prolongation, cardiac arrhythmias, hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • rasagiline
  • Coreg (carvedilol)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    carvedilol + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • red yeast rice
  • Coreg (carvedilol)
    +
    red yeast rice
    1 interaction

    Monitor/Modify Tx

    carvedilol + red yeast rice

    monitor CK, myopathy sx w/ large amounts of red yeast rice: combo may incr. lovastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited, red yeast rice contains varying amounts of lovastatin)

  • regadenoson
  • Coreg (carvedilol)
    +
    regadenoson
    1 interaction

    Monitor/Modify Tx

    carvedilol + regadenoson

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • regorafenib
  • Coreg (carvedilol)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    carvedilol + regorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • remifentanil
  • Coreg (carvedilol)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    carvedilol + remifentanil

    monitor BP, HR: combo may incr. risk of bradycardia, severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Coreg (carvedilol)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    carvedilol + remimazolam

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • repaglinide
  • Coreg (carvedilol)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    carvedilol + repaglinide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • rifabutin
  • Coreg (carvedilol)
    +
    rifabutin
    1 interaction

    Monitor/Modify Tx

    carvedilol + rifabutin

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced)

  • rifampin
  • Coreg (carvedilol)
    +
    rifampin
    1 interaction

    Monitor/Modify Tx

    carvedilol + rifampin

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (hepatic metabolism induced, P-gp-mediated transport induced)

  • rifapentine
  • Coreg (carvedilol)
    +
    rifapentine
    1 interaction

    Monitor/Modify Tx

    carvedilol + rifapentine

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced)

  • rimegepant
  • Coreg (carvedilol)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    carvedilol + rimegepant

    monitor BP; consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • riociguat
  • Coreg (carvedilol)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    carvedilol + riociguat

    monitor BP: combo may incr. riociguat levels, risk of severe hypotension, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • ripretinib
  • Coreg (carvedilol)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + ripretinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • risperidone
  • Coreg (carvedilol)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ritonavir
  • Coreg (carvedilol)
    +
    ritonavir
    1 interaction

    Monitor/Modify Tx

    carvedilol + ritonavir

    monitor BP, HR; consider monitoring ECG: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • rizatriptan
  • Coreg (carvedilol)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + rizatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ropinirole
  • Coreg (carvedilol)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    carvedilol + ropinirole

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • ropivacaine
  • Coreg (carvedilol)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    carvedilol + ropivacaine

    monitor BP, HR: combo may incr. risk of hypotension, bradycardia (additive effects)

  • rosiglitazone
  • Coreg (carvedilol)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    carvedilol + rosiglitazone

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (antagonistic effects, additive effects)

  • rotigotine transdermal
  • Coreg (carvedilol)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    carvedilol + rotigotine transdermal

    monitor BP: combo may alter blood pressure control (antagonistic effects, additive effects)

  • sacubitril
  • Coreg (carvedilol)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    carvedilol + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Coreg (carvedilol)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    carvedilol + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • salsalate
  • Coreg (carvedilol)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    carvedilol + salsalate

    monitor BP w/ high-dose salsalate: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • saxagliptin
  • Coreg (carvedilol)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    carvedilol + saxagliptin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • selegiline
  • Coreg (carvedilol)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    carvedilol + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Coreg (carvedilol)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    carvedilol + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selpercatinib
  • Coreg (carvedilol)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + selpercatinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • semaglutide
  • Coreg (carvedilol)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    carvedilol + semaglutide

    monitor glucose in type 2 diabetes mellitus pts; consider monitoring glucose in obesity pts: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • sevoflurane
  • Coreg (carvedilol)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    carvedilol + sevoflurane

    monitor BP: combo may cause prolonged hypotension, decr. cardiac output, other myocardial depressant effects (additive effects)

  • sildenafil
  • Coreg (carvedilol)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    carvedilol + sildenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • silodosin
  • Coreg (carvedilol)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    carvedilol + silodosin

    monitor BP: combo may incr. silodosin levels, risk of hypotension (including orthostasis, syncope), other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • simvastatin
  • Coreg (carvedilol)
    +
    simvastatin
    1 interaction

    Monitor/Modify Tx

    carvedilol + simvastatin

    monitor CK, myopathy sx: combo may incr. simvastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited)

  • sirolimus
  • Coreg (carvedilol)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    carvedilol + sirolimus

    monitor sirolimus levels: combo may incr. sirolimus levels, risk of serious infection, other adverse effects (P-gp-mediated transport inhibited)

  • sitagliptin
  • Coreg (carvedilol)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    carvedilol + sitagliptin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • sodium ferric gluconate complex
  • Coreg (carvedilol)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    carvedilol + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • sorafenib
  • Coreg (carvedilol)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    carvedilol + sorafenib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sotagliflozin
  • Coreg (carvedilol)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    carvedilol + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotorasib
  • Coreg (carvedilol)
    +
    sotorasib
    1 interaction

    Monitor/Modify Tx

    carvedilol + sotorasib

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • sparsentan
  • Coreg (carvedilol)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    carvedilol + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • St. John's wort
  • Coreg (carvedilol)
    +
    St. John's wort
    1 interaction

    Monitor/Modify Tx

    carvedilol + St. John's wort

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport induced)

  • succinylcholine
  • Coreg (carvedilol)
    +
    succinylcholine
    1 interaction

    Monitor/Modify Tx

    carvedilol + succinylcholine

    monitor HR: combo may incr. risk of bradycardia (additive effects)

  • sufentanil
  • Coreg (carvedilol)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    carvedilol + sufentanil

    monitor BP, HR: combo may incr. risk of bradycardia, severe hypotension, including orthostasis, syncope (additive effects)

  • sugammadex
  • Coreg (carvedilol)
    +
    sugammadex
    1 interaction

    Monitor/Modify Tx

    carvedilol + sugammadex

    monitor HR: combo may incr. risk of bradycardia (additive effects)

  • sulindac
  • Coreg (carvedilol)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    carvedilol + sulindac

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sumatriptan
  • Coreg (carvedilol)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + sumatriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sunitinib
  • Coreg (carvedilol)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + sunitinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tacrolimus
  • Coreg (carvedilol)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    carvedilol + tacrolimus

    monitor tacrolimus levels, ECG, BP, renal fxn: combo may incr. tacrolimus levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • tadalafil
  • Coreg (carvedilol)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    carvedilol + tadalafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tagraxofusp
  • Coreg (carvedilol)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    carvedilol + tagraxofusp

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • tamsulosin
  • Coreg (carvedilol)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    carvedilol + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Coreg (carvedilol)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    carvedilol + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Coreg (carvedilol)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    carvedilol + taurine

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • tenofovir alafenamide
  • Coreg (carvedilol)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    carvedilol + tenofovir alafenamide

    if tenofovir alafenamide not admin. w/ cobicistat, monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (gut P-gp-mediated transport inhibited)

  • tenofovir disoproxil
  • Coreg (carvedilol)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    carvedilol + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (gut P-gp-mediated transport inhibited)

  • tepotinib
  • Coreg (carvedilol)
    +
    tepotinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + tepotinib

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • terazosin
  • Coreg (carvedilol)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    carvedilol + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbinafine
  • Coreg (carvedilol)
    +
    terbinafine
    1 interaction

    Monitor/Modify Tx

    carvedilol + terbinafine

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (hepatic metabolism inhibited)

  • teriflunomide
  • Coreg (carvedilol)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    carvedilol + teriflunomide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • testosterone
  • Coreg (carvedilol)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    carvedilol + testosterone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tetrahydrozoline ophthalmic
  • Coreg (carvedilol)
    +
    tetrahydrozoline ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + tetrahydrozoline ophthalmic

    consider monitoring BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • thalidomide
  • Coreg (carvedilol)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    carvedilol + thalidomide

    monitor BP, HR: combo may incr. risk of bradycardia, hypotension, including orthostasis (additive effects)

  • thioridazine
  • Coreg (carvedilol)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Coreg (carvedilol)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    carvedilol + thiothixene

    monitor BP: combo may incr. risk of hypotension, syncope (additive effects)

  • thyroid
  • Coreg (carvedilol)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    carvedilol + thyroid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ticagrelor
  • Coreg (carvedilol)
    +
    ticagrelor
    1 interaction

    Monitor/Modify Tx

    carvedilol + ticagrelor

    monitor HR: combo may incr. risk of PR interval prolongation, AV block, bradycardia (additive effects)

  • timolol ophthalmic
  • Coreg (carvedilol)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    carvedilol + timolol ophthalmic

    monitor BP, HR, IOP: combo may incr. risk of hypotension, PR interval prolongation, AV block, bradycardia, excessively decr. IOP (additive effects)

  • tipranavir
  • Coreg (carvedilol)
    +
    tipranavir
    1 interaction

    Monitor/Modify Tx

    carvedilol + tipranavir

    monitor BP, HR: combo may incr. or decr. carvedilol levels, incr. risk of hypotension, bradycardia, AV block, other adverse effects or decr. efficacy (P-gp-mediated transport altered)

  • tirzepatide
  • Coreg (carvedilol)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    carvedilol + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • Coreg (carvedilol)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    carvedilol + tivozanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tizanidine
  • Coreg (carvedilol)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    carvedilol + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Coreg (carvedilol)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    carvedilol + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolmetin
  • Coreg (carvedilol)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    carvedilol + tolmetin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tramadol
  • Coreg (carvedilol)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    carvedilol + tramadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • trametinib
  • Coreg (carvedilol)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + trametinib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tranylcypromine
  • Coreg (carvedilol)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    carvedilol + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Coreg (carvedilol)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    carvedilol + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Coreg (carvedilol)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    carvedilol + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • triamcinolone
  • Coreg (carvedilol)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    carvedilol + triamcinolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trifluoperazine
  • Coreg (carvedilol)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Coreg (carvedilol)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    carvedilol + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tucatinib
  • Coreg (carvedilol)
    +
    tucatinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + tucatinib

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • turmeric
  • Coreg (carvedilol)
    +
    turmeric
    1 interaction

    Monitor/Modify Tx

    carvedilol + turmeric

    monitor BP, HR w/ oral turmeric: combo may incr. or decr. carvedilol levels, incr. risk of hypotension, bradycardia, AV block, other adverse effects or decr. efficacy (P-gp-mediated transport altered)

  • ubrogepant
  • Coreg (carvedilol)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    carvedilol + ubrogepant

    monitor BP; limit ubrogepant dose to 50 mg, may give second 50 mg dose after 2h if needed: combo may incr. ubrogepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • vaborbactam
  • Coreg (carvedilol)
    +
    vaborbactam
    1 interaction

    Monitor/Modify Tx

    carvedilol + vaborbactam

    monitor BP, HR: combo may decr. carvedilol levels, efficacy (P-gp-mediated transport possibly induced)

  • vadadustat
  • Coreg (carvedilol)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    carvedilol + vadadustat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Coreg (carvedilol)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    carvedilol + vamorolone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vandetanib
  • Coreg (carvedilol)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    carvedilol + vandetanib

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vardenafil
  • Coreg (carvedilol)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    carvedilol + vardenafil

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • vasopressin
  • Coreg (carvedilol)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    carvedilol + vasopressin

    monitor BP: combo may decr. efficacy of both drugs (antagonistic effects)

  • vemurafenib
  • Coreg (carvedilol)
    +
    vemurafenib
    1 interaction

    Monitor/Modify Tx

    carvedilol + vemurafenib

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • venlafaxine
  • Coreg (carvedilol)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    carvedilol + venlafaxine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • verapamil
  • Coreg (carvedilol)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    carvedilol + verapamil

    monitor ECG, BP, HR: combo may incr. carvedilol levels, risk of hypotension, PR interval prolongation, AV block, bradycardia, other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • viloxazine
  • Coreg (carvedilol)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    carvedilol + viloxazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vimseltinib
  • Coreg (carvedilol)
    +
    vimseltinib
    1 interaction

    Monitor/Modify Tx

    carvedilol + vimseltinib

    monitor BP, HR; give vimseltinib at least 4h before carvedilol: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • voclosporin
  • Coreg (carvedilol)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    carvedilol + voclosporin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vosoritide
  • Coreg (carvedilol)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    carvedilol + vosoritide

    monitor BP: combo may incr. risk of hypotension (additive effects)

  • voxilaprevir
  • Coreg (carvedilol)
    +
    voxilaprevir
    1 interaction

    Monitor/Modify Tx

    carvedilol + voxilaprevir

    monitor BP, HR: combo may incr. carvedilol levels, risk of hypotension, bradycardia, AV block, other adverse effects (gut P-gp-mediated transport inhibited)

  • yohimbe
  • Coreg (carvedilol)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    carvedilol + yohimbe

    monitor BP: combo may alter blood pressure control (additive effects, antagonistic effects)

  • zavegepant
  • Coreg (carvedilol)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    carvedilol + zavegepant

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ziprasidone
  • Coreg (carvedilol)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    carvedilol + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ziv-aflibercept
  • Coreg (carvedilol)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    carvedilol + ziv-aflibercept

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • zolmitriptan
  • Coreg (carvedilol)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    carvedilol + zolmitriptan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

Caution Advised

  • aliskiren
  • Coreg (carvedilol)
    +
    aliskiren
    1 interaction

    Caution Advised

    carvedilol + aliskiren

    caution advised: combo may incr. aliskiren levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • cevimeline
  • Coreg (carvedilol)
    +
    cevimeline
    1 interaction

    Caution Advised

    carvedilol + cevimeline

    caution advised: combo may alter cardiac conduction (additive effects)

  • darolutamide
  • Coreg (carvedilol)
    +
    darolutamide
    1 interaction

    Caution Advised

    carvedilol + darolutamide

    if also combined w/ strong CYP3A4 inhibitor, caution advised: combo may incr. darolutamide levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • methacholine inhaled
  • Coreg (carvedilol)
    +
    methacholine inhaled
    1 interaction

    Caution Advised

    carvedilol + methacholine inhaled

    caution advised: carvedilol may impair reversal/prolong methacholine-induced bronchoconstriction; beta-1 cardioselective agents less likely to interact (additive effects)

  • naldemedine
  • Coreg (carvedilol)
    +
    naldemedine
    1 interaction

    Caution Advised

    carvedilol + naldemedine

    caution advised: combo may incr. naldemedine levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • pilocarpine
  • Coreg (carvedilol)
    +
    pilocarpine
    1 interaction

    Caution Advised

    carvedilol + pilocarpine

    caution advised: combo may alter cardiac conduction (additive effects)

  • tasimelteon
  • Coreg (carvedilol)
    +
    tasimelteon
    1 interaction

    Caution Advised

    carvedilol + tasimelteon

    caution advised: combo may decr. tasimelteon efficacy (antagonistic effects; beta-blockers may decr. melatonin production)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@24450960
  • CHF
  • bradycardia, severe
  • heart block
  • angina exacerbation
  • angina exacerbation if abrupt D/C
  • MI if abrupt D/C
  • ventricular arrhythmia if abrupt D/C
  • asthma
  • bronchospasm
  • hypersensitivity reaction
  • anaphylactoid reaction
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • erythema multiforme
  • exfoliative dermatitis
  • photosensitivity
  • lupus erythematosus
  • pneumonitis, interstitial
  • leukopenia
  • thrombocytopenia
  • anemia
  • aplastic anemia
  • intraoperative floppy iris syndrome

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@21cc510d
  • dizziness
  • fatigue
  • diarrhea
  • hyperglycemia
  • weight gain
  • hypotension
  • bradycardia
  • dyspnea
  • nausea
  • headache
  • asthenia
  • vomiting
  • arthralgia
  • BUN elevated
  • visual disturbance
  • edema
  • hypercholesterolemia
  • rales
  • syncope
  • angina
  • anemia
  • pulmonary edema
  • ALT or AST elevated

Safety/Monitoring .

Monitoring Parameters
BUN/Cr with dose incr. if renal impairment risk; in diabetes patients, glucose at tx start, dose change, and D/C; BP, HR

Look/Sound-Alike Drug Names
Coreg confused with: Corgard; Cortef; Cortone Acetate; Cozaar


carvedilol confused with: atenolol; captopril; carbidopa; carteolol

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 2nd and 3rd trimesters; inadequate human data available, though possible risk of intrauterine growth restriction; no known risk of teratogenicity, though possible risk of neonatal adverse effects, including bradycardia and hypoglycemia, based on limited human data with other beta blockers

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@85c39c0

Metabolism: for carvedilol: liver extensively; CYP450:1A2, 2C9/19, 2D6 (primary), 2E1, 3A4 substrate

Excretion: for carvedilol: feces 60%, urine 16% (<2% unchanged); Half-life: 6-10h

Subclass: Antiarrhythmics, Oral ; Beta Blockers

Mechanism of Action
for carvedilol: selectively antagonizes alpha-1 adrenergic receptors; antagonizes beta-1 and beta-2 adrenergic receptors (selective alpha and non-selective beta blocker)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Waylis Therapeutics LLC

com.epocrates.rxweb.beans.DrugOtherInfoBean@3ebfa763

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 3.125 mg (60 ea): $372.00
  • 6.25 mg (60 ea): $372.00
  • 12.5 mg (60 ea): $372.00
  • 25 mg (60 ea): $372.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information